InnovAge Holding Corp. (INNV) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 203.89M USD | Liabilities, Current |
| Cash and equivalents | 97.89M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 42.39M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $203.89M | $97.89M | (m) | $42.39M | (m) | (m) |
| 2026-03-31 | (m) | $195.89M | $95.54M | (m) | $28.58M | (m) | (m) |
| 2025-12-31 | (m) | $144.70M | $83.20M | (m) | $21.30M | (m) | (m) |
| 2025-09-30 | (m) | $138.49M | $67.15M | (m) | $23.17M | (m) | (m) |
| 2025-06-30 | (m) | $164.81M | $64.13M | (m) | $36.37M | (m) | (m) |
| 2025-03-31 | (m) | $225.32M | $60.45M | (m) | $44.40M | (m) | (m) |
| 2024-12-31 | (m) | $144.97M | $46.08M | (m) | $49.76M | (m) | (m) |
| 2024-09-30 | (m) | $131.35M | $39.02M | (m) | $46.73M | (m) | (m) |
| 2024-06-30 | (m) | $138.60M | $56.95M | (m) | $48.11M | (m) | (m) |
| 2024-03-31 | (m) | $121.97M | $54.09M | (m) | $36.46M | (m) | (m) |
| 2023-12-31 | (m) | $123.13M | $54.08M | (m) | $43.46M | (m) | (m) |
| 2023-09-30 | (m) | $138.81M | $88.40M | (m) | $44.19M | (m) | (m) |
| 2023-06-30 | (m) | $148.45M | $127.25M | (m) | $24.34M | (m) | (m) |
| 2023-03-31 | (m) | $137.69M | $121.71M | (m) | $34.20M | (m) | (m) |
| 2022-12-31 | (m) | $106.19M | $99.46M | (m) | $38.64M | (m) | (m) |
| 2022-09-30 | (m) | $131.41M | $188.22M | (m) | $37.52M | (m) | (m) |
| 2022-06-30 | (m) | $105.31M | $184.43M | (m) | $35.91M | (m) | (m) |
| 2022-03-31 | (m) | $94.39M | $199.49M | (m) | $31.91M | (m) | (m) |
| 2021-12-31 | (m) | $89.32M | $216.31M | (m) | $33.29M | (m) | (m) |
| 2021-09-30 | (m) | $81.15M | $215.53M | (m) | $28.39M | (m) | (m) |
| 2021-06-30 | (m) | $78.56M | $201.47M | (m) | $32.58M | (m) | (m) |
| 2021-03-31 | (m) | $93.98M | $201.53M | (m) | $44.36M | (m) | (m) |
| 2020-06-30 | (m) | $76.63M | $112.90M | (m) | $46.31M | (m) | (m) |
| 2019-03-18 | (m) | (m) | $9.00M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |